Presentation Unfractionated Heparin vs Bivalirudin in Primary PCI: An Open-label, Single-Center, Randomized Trial Presenter: A. Shahzad July 10, 2014 REGISTER for free or LOG IN to view this content CAD Pharma ACS/AMI Factoid Up Next Presentation PARTNER: Comprehensive Analysis of Mortality Among Patients Undergoing TAVR Presenter: Lars G. Svensson July 10, 2014 More slides + Presentation Impact of Symptoms, Gender, Comorbidities, and Operator Volume on Outcomes of CAS Presenter: Apurva O. Badheka July 11, 2014 Presentation The Efficacy of “Hybrid” PCI in CTOs Caused by In-Stent Restenosis Presenter: G. Christopoulos July 14, 2014 We Recommend
Presentation PARTNER: Comprehensive Analysis of Mortality Among Patients Undergoing TAVR Presenter: Lars G. Svensson July 10, 2014
Presentation Impact of Symptoms, Gender, Comorbidities, and Operator Volume on Outcomes of CAS Presenter: Apurva O. Badheka July 11, 2014
Presentation The Efficacy of “Hybrid” PCI in CTOs Caused by In-Stent Restenosis Presenter: G. Christopoulos July 14, 2014